It is CagriSema: cagrilintide 2.4 mg combined with semaglutide 2.4 mg
All Cenexa peptide products are sold strictly for research and laboratory use only not for human or animal consumption
It requires sterile technique, causes discomfort for needle-averse individuals, creates potential injection site reactions, and demands careful rotation to avoid tissue damage over extended protocols
Which Peptides Are Expected to Return and What the Science Says Which Peptides Are Expected to Return and What the Science Says Based on the February 2026 announcement and analysis from compounding pharmacy associations and regulatory experts, approximately 14 of the 19 restricted peptides are expected to return to Category 1 status
All too many times, however, we see patients with arterial stiffness that can ultimately lead to many of the issues above, including cardiovascular disease and death
I mentioned it briefly above but I want to dive into a little more detail here
